Due to an error introduced during copyediting, the title of the publication by Barna et al. (2018) contained a typo. The title has since been corrected. The publisher apologizes for this error.
No CrossRef data available.
EVIDENCE REQUIRED BY HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT BODIES EVALUATING DIAGNOSTIC OR PROGNOSTIC ALGORITHMS THAT INCLUDE OMICS DATA – ERRATUM
Published online by Cambridge University Press: 23 October 2018
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
- Type
- Erratum
- Information
- International Journal of Technology Assessment in Health Care , Volume 34 , Issue 5 , 2018 , pp. 535
- Copyright
- Copyright © Cambridge University Press 2018
References
REFERENCE
1.Barna, A, et al. Evidence required by health technology assessment and reimbursement bodies evaluating diagnostic or prognostic algorithms that include omics data. International Journal of Technology Assessment in Health Care. 2018;34:368–377 doi: 10.1017/S026646231800048X.Google Scholar
This correction applies to the following article(s):
You have
Access